4894 Cuorips
- 7500
- -600-7.41%
Cuorips News
The Growth Market 250 Index continues to battle the 75-day line, with interest turning to recent IPOs.
Expectations for a fresh start: This week, the emerging markets are expected to have a solid footing, as they dealt with profit-taking sales for short-term price increases. In the prime market this week, there is an expectation of over one trillion yen in sell-offs related to the earnings of listed ETFs. Although it is considered to be factored into the market to some extent, it may be a psychological burden due to last week's significant increase. As a result, there is a possibility of cyclical searches in the emerging markets. In the first half of last week, emerging markets underwent profit-taking.
Emerging markets outlook: Will the growth market 250 index continue to battle the 75-day line and shift focus to recent IPOs?
Trading volume stagnated in the market led by large cap shareholders and the emerging market fell this week. During the same period, while the Nikkei Stock Average increased by +3.36%, the growth market index and growth market 250 index decreased by -0.56% and -0.57%, respectively, making the emerging markets dominated by the main board. Funds continued to flow toward financial stocks and precision instrument stocks in the main board market, and on July 4, the Nikkei Stock Average and TOPIX both reached the highest level in history. The market capitalization of the main board market also reached a record high of 1000 for the first time.
Cuorips: Interim report
The index ETF of Growth 250 is continuing to battle against the 75-day moving average, and biotech-related stocks remain the focus of the market.
An emerging market is likely to see profit-taking sales against the current rebound, but expect a strong outlook against the backdrop of improving investor sentiment. The Growth Market 250 Index is testing the 75-day moving average breakthrough. On June 27th, it exceeded the 75-day moving average on a closing price basis for the first time since April 1st, but over the weekend, it fell below this level. With the 25-day moving average firmly upward, this week will see a further rise to 200.
Emerging markets outlook: Growth 250 index continues to battle with its 75-day moving average, while biotech remains the focus of buying interest.
The emerging markets have been showing a clear upward trend on a monthly basis in June. In contrast with the Nikkei average's +2.56%, the growth market index rose by +3.43%, and the growth market 250 index increased by +3.65%, making it a favorable situation for emerging markets. Bio stocks were generally bought, with Sanbio <4592> rising four consecutive limits, and large-cap stocks were also strong, so the growth market index has risen for six consecutive days until June 27, and the growth market 250 index...
Stocks that moved the day before Part 2: Kura Sushi, GMO-AP, Daun, etc.
Brand name <code> 28th closing price ⇒ Previous day comparison Kura Sushi <2695> 4045-300 Negative view of the consolidated interim settlement of its subsidiary Yonago. Hino Motors <7205> 418.0-24.0 UBS Securities downgrades investment judgment. M & A Soken <9552> 4015-285 awareness of one-round feeling even with the movement of the rebound. Kose <4922> 10235-385 coverage started with a target of 10,000 yen at Jefferies Securities. Hokkaido Electric Utilities <9509> 1194-33.
The TOPIX 250 index on the Tokyo Stock Exchange has risen for four consecutive days, with biotechnology stocks reaching their limit highs across the board.
The Tokyo Stock Exchange Growth Market Index was 859.31, up 15.31 with a volume of 254.6 million shares and a turnover of 179.6 billion yen. The Tokyo Stock Exchange Growth Market 250 Index was 668.3, up 13.22 with a volume of 121.78 million shares and a turnover of 110.2 billion yen. Today's Growth Market saw the Tokyo Stock Exchange Growth Market Index rise for the 6th consecutive day and the Tokyo Stock Exchange Growth Market 250 Index rise for the 4th consecutive day. The number of rising stocks was 336, the number of falling stocks was 210, and the unchanged stocks were 33. The US stock market rose on the 26th, with the Dow average at 15.
Cuorips: Confirmatory letter.
Cuorips: Securities Report - 8th term (April 1, 2023 to March 31, 2024)
Emerging market stock digest: Technology continues to rise, Qualipus hits the daily limit up.
<4015> PayCloud 516 continued to rise by 33. After the close of trading on the 26th, the monthly performance report for May was released. Monthly recurring revenue (MRR) increased by 19% compared to the same month last year, which was well-received. MRR increased by 23% when limited to cashless services. The cumulative number of IDs is 230 million (an increase of about 200,000 compared to the previous month), the cumulative number of stores is 123,295 (an increase of 451 compared to the previous month), and the cumulative number of digital signage installations is 55,150 (an increase of 900).
Technologies, Modalis, and others.
<4894> Qualipus has established a subsidiary in the USA <5248> Technology stock splits, from 6 shares to 1 share <4883> Modalis has exercised a large number of 12th new share subscription rights (with exercise price adjustment clause), with 880,000 shares of stock to be delivered from the 4th onwards.
Part 2 of previous day's moving stocks include Miyoshi Oil & Fat, Qualipps, Sanbio, etc.
Stock name <Code> 25-day closing price ⇒ Day-on-day comparison Laser Tech <6920> 35260 -1160 Semiconductor-related representative stocks are generally cheap. Tokyo Ohka Kogyo <4186> 4280 -130 Selling spreads as part of the semiconductor-related market. Vision <9416> 1217 -1 Significantly higher on the performance and dividend estimates revision on the 24th. Tokyo Electron Ltd. unsponsored ADR <8035> 34400 -590 SEMICONDUCTOR Manufacturing equipment is generally cheap due to the significant drop in the US SOX index. Renesas Electronics
The Nikkei 250 index on the Tokyo Stock Exchange continued to rise, as the increase in biotech-related stocks stimulated investor confidence.
Tokyo Stock Exchange Growth Market Index 835.17 +10.18 / volume 161,370,000 shares / trading value 137.1 billion yen. Tokyo Stock Exchange Growth Market 250 index 647.30 +8.53 / volume 77,980,000 shares / trading value 85.7 billion yen. Today's growth market, the Tokyo Stock Exchange Growth Market Index rose for the fourth consecutive day, and the Tokyo Stock Exchange Growth Market 250 Index also rose. The number of rising stocks was 362, the number of declining stocks was 177, and the unchanged stocks were 42. The US stock market on the 24th was mixed. The Dow Jones Industrial Average fell 260.8 points.
Active and newly listed stocks during the morning session.
*Tiger Gaia <3738> 2865 yen - Continuation of the trend of restructuring speculation. *Unichika <3103> 364 yen +32 - Development of polyester polymerization technology using catalysts that do not use metals is seen as a material. *IHI <7013> 4369 yen +288 - Installation of a manufacturing test device for SAF synthesis technology development was announced the previous day. *Akebono Brake Industry <7238> 164 yen +7 - Announced the recording of gains on the sale of investment securities. *Avex <7860> 1317 yen +61 - Due to the recording of special profits.
Stocks that hit the daily limit up or down in the morning session.
- Stop limit up: WOLVES HAND (4199), Wonder Planet (4592), Sanbio (4894), Quolip (7083), AHC Group (7815), Tokyo Board Industry. - Stop limit down: Espoa (3260) *Includes temporary stop limit up and down (indication value).
Stocks that moved the day before part1 include Teigaia, FP Partner, Qualipus, and others.
Stock name <Code> 24-day closing price ⇒ Previous day comparison Nova Leze <9160> 321 +25 TKP <3479> and capital business tie-up. Assointha <9340> 1,155 +82 announced the sale of dental engineering products "ZERO TUBE SYSTEM". Okura Works <4221> 2,849 +74 announced sales and share buybacks. Rentorax <6045> 455 +245 revenue in May increased by 33.3% and growth rate expanded from 5.0% increase in April. G-NEXT <4179>
The TOPIX index slightly rose for the third consecutive day, with a focus on material stocks and recent IPOs.
Tokyo Stock Exchange Growth Market Index 824.99 +1.77 / Volume 134 million shares / Trading value 142.6 billion yen Tokyo Stock Exchange Growth Market 250 Index 638.77 +0.79 / Volume 83.16 million shares / Trading value 90.1 billion yen Today's growth market, the Tokyo Stock Exchange Growth Market Index rose for the third consecutive day, while the Tokyo Stock Exchange Growth Market 250 Index rebounded slightly. The number of rising stocks is 322, the number of falling stocks is 219, and the unchanged is 40. On the 21st of the United States market, the Dow Jones Industrial Average was up $15.57.
Stocks hitting the upper or lower price limit in the afternoon session.
Stop high <155A>, information strategy technology <184A>, Learning Aid <194A>, WOLVES HAND <196A>, MFS <198A>, PostPrime <3738>, Tea Gaia <4360>, Manac Chemical Partners <4592>, Sun Bio <4884>, Cringle Pharma <7083>, AHC Group <7997>, Kurogane Factory Stop low <4894>, Qualypus * including temporary stop highs and lows (quote values)
Despite the downward pressure from softness and firmness in long-term US Treasury yields, the downside is expected to remain strong.
[Emerging Markets Individual Stock Strategy] Today's emerging markets are expected to have a weak development. In the U.S. stock market on the 21st, the Dow Jones Industrial Average rose slightly for the fourth consecutive day, up 15.57 dollars (+ 0.04%) to 39,150.33 dollars. While selling for profit adjustments of U.S. stock-related options, which concentrate on options expiration day, emerged, buying supported stocks that had a sense of delay. On the other hand, following the previous day, Nvidia and Micron Technology, both of which deal with semiconductors, were sold for Nasdaq, down 0.18%.
Asukanet, Renascience, and others.
<2438> Asukanet conducts a share buyback of up to 340,000 shares (2.07% of the issued shares) for purchase on ToSTNeT-3 on the 24th. <3479> TKP Nova and <9160> Maika enter into a capital and business alliance, while <4179> G Next signs a basic agreement for a capital and business partnership candidate joint development that handles consulting related to corporate governance. <4889> Renascience deals with pyridoxine for premenstrual syndrome / premenstrual dysphoric disorder with psychotic symptoms.
Analysis
Price Target
No Data
